This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0-ballot: STU 1 Ballot 3) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: valueset-cyclosporine-exclude - JSON Representation

Raw json | Download

{
  "resourceType" : "ValueSet",
  "id" : "valueset-cyclosporine-exclude",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1093178</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]</td></tr><tr><td>402092</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]</td></tr><tr><td>1093177</td><td>Cyclosporine Ophthalmic Ointment [Optimmune]</td></tr><tr><td>402330</td><td>Cyclosporine Ophthalmic Suspension [Restasis]</td></tr><tr><td>1093174</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment</td></tr><tr><td>351291</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension</td></tr><tr><td>1093173</td><td>Cyclosporine Ophthalmic Ointment</td></tr><tr><td>378766</td><td>Cyclosporine Ophthalmic Suspension</td></tr><tr><td>1156187</td><td>Cyclosporine Ophthalmic Product</td></tr><tr><td>1182342</td><td>Optimmune Ophthalmic Product</td></tr><tr><td>1182527</td><td>Restasis Ophthalmic Product</td></tr></table></li></ul></div>"
  },
  "url" : "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude",
  "version" : "1.0.0-ballot",
  "name" : "Valueset_cyclosporine_exclude",
  "title" : "Exclude cyclosporine Medications Value Set",
  "status" : "draft",
  "experimental" : true,
  "date" : "2018-07-02",
  "publisher" : "HL7 Clinical Decision Support Workgroup",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description" : "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001"
        }
      ]
    }
  ],
  "purpose" : "To refine valueset for Digoxin + Cyclosporine PDDI-CDS",
  "copyright" : "(copyright expectations unknown)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1093178",
            "display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]"
          },
          {
            "code" : "402092",
            "display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]"
          },
          {
            "code" : "1093177",
            "display" : "Cyclosporine Ophthalmic Ointment [Optimmune]"
          },
          {
            "code" : "402330",
            "display" : "Cyclosporine Ophthalmic Suspension [Restasis]"
          },
          {
            "code" : "1093174",
            "display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment"
          },
          {
            "code" : "351291",
            "display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension"
          },
          {
            "code" : "1093173",
            "display" : "Cyclosporine Ophthalmic Ointment"
          },
          {
            "code" : "378766",
            "display" : "Cyclosporine Ophthalmic Suspension"
          },
          {
            "code" : "1156187",
            "display" : "Cyclosporine Ophthalmic Product"
          },
          {
            "code" : "1182342",
            "display" : "Optimmune Ophthalmic Product"
          },
          {
            "code" : "1182527",
            "display" : "Restasis Ophthalmic Product"
          }
        ]
      }
    ]
  }
}